Women Taking Mounjaro and Zepbound Experience Greater Weight Loss Than Men

Wednesday, 11 September 2024, 15:00

Women taking Mounjaro and Zepbound in a recent study lost more weight than their male counterparts. The findings suggest that GLP-1s like Mounjaro greatly contribute to weight reduction for all participants. Notably, all doses showed significant total body weight decreases across genders, emphasizing the effectiveness of these medications.

Forbes — Women Taking Mounjaro and Zepbound Experience Greater Weight Loss Than Men

Study Overview

In a recent clinical trial, it was revealed that women taking Mounjaro and Zepbound experienced greater weight loss compared to men. This groundbreaking research highlights the impact of GLP-1s on body weight management.

Key Findings

Women lost significantly more weight.
All participants benefited from weight loss on all Mounjaro and Zepbound doses.
The study emphasizes the role of GIP in enhancing weight loss outcomes.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Study Overview

Key Findings

Related posts